BDNF Regulates the Expression of Fragile X Mental Retardation Protein mRNA in the Hippocampus

Both fragile X mental retardation protein (FMRP) and brain-derived neurotrophic factor (BDNF) are implicated in the maturation of neurons and in the higher cognitive functions. We have investigated whether FMRP and BDNF are reciprocally regulated in neurons. Exposure of cultured hippocampal neurons to BDNF, but not to NT-3, reduced FMR1 mRNA levels to 84.8% of control at 4 h and the levels were back to baseline by 24 h or 4 days. Furthermore, expression of FMR1 mRNA was reduced (82.4% of control) in vivo in the hippocampus of transgenic mice overexpressing TrkB receptors, and a small but significant (5.1%) decrease was also detected in FMRP protein levels. In contrast, the expression patterns of BDNF and TrkB mRNAs were not altered in FMRP-deficient mice compared to wild-type mice. Our data provide evidence that BDNF via TrkB signaling decreases FMRP expression and suggest a role for FMRP in BDNF-induced synaptic plasticity.

[1]  Mark F. Bear,et al.  Altered synaptic plasticity in a mouse model of fragile X mental retardation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[2]  E. Castrén,et al.  Decreased BDNF signalling in transgenic mice reduces epileptogenesis , 2002, The European journal of neuroscience.

[3]  J. Mandel,et al.  Do G Quartets Orchestrate Fragile X Pathology? , 2001, Science.

[4]  Gerald M. Rubin,et al.  Drosophila Fragile X-Related Gene Regulates the MAP1B Homolog Futsch to Control Synaptic Structure and Function , 2001, Cell.

[5]  J. Darnell,et al.  Fragile X Mental Retardation Protein Targets G Quartet mRNAs Important for Neuronal Function , 2001, Cell.

[6]  J. Darnell,et al.  Microarray Identification of FMRP-Associated Brain mRNAs and Altered mRNA Translational Profiles in Fragile X Syndrome , 2001, Cell.

[7]  Karel Svoboda,et al.  Abnormal Development of Dendritic Spines inFMR1 Knock-Out Mice , 2001, The Journal of Neuroscience.

[8]  E. Castrén,et al.  Subcellular Localization of Fragile X Mental Retardation Protein with the I304N Mutation in the RNA-Binding Domain in Cultured Hippocampal Neurons , 2001, Cellular and Molecular Neurobiology.

[9]  P. Sokoloff,et al.  BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization , 2001, Nature.

[10]  A. Ostareck-Lederer,et al.  Evidence that fragile X mental retardation protein is a negative regulator of translation. , 2001, Human molecular genetics.

[11]  I. Weiler,et al.  Abnormal dendritic spine characteristics in the temporal and visual cortices of patients with fragile-X syndrome: a quantitative examination. , 2001, American journal of medical genetics.

[12]  E. Castrén,et al.  Transgenic mice overexpressing truncated trkB neurotrophin receptors in neurons have impaired long‐term spatial memory but normal hippocampal LTP , 2000, Synapse.

[13]  W. Greenough,et al.  Dendritic spine structural anomalies in fragile-X mental retardation syndrome. , 2000, Cerebral cortex.

[14]  M. Segal,et al.  FMRP involvement in formation of synapses among cultured hippocampal neurons. , 2000, Cerebral cortex.

[15]  Peter K. Todd,et al.  Sensory stimulation increases cortical expression of the fragile X mental retardation protein in vivo. , 2000, Brain research. Molecular brain research.

[16]  David R Kaplan,et al.  Neurotrophin signal transduction in the nervous system , 2000, Current Opinion in Neurobiology.

[17]  D. Nelson,et al.  (Over)correction of FMR1 deficiency with YAC transgenics: behavioral and physical features. , 2000, Human molecular genetics.

[18]  P. Jin,et al.  Understanding the molecular basis of fragile X syndrome. , 2000, Human molecular genetics.

[19]  M. Stryker,et al.  Cortical Degeneration in the Absence of Neurotrophin Signaling Dendritic Retraction and Neuronal Loss after Removal of the Receptor TrkB , 2000, Neuron.

[20]  J. Sarvey,et al.  Fragile X (fmr1) mRNA expression is differentially regulated in two adult models of activity-dependent gene expression. , 2000, Brain research. Molecular brain research.

[21]  Raffaele Ferri,et al.  Audiogenic Seizures Susceptibility in Transgenic Mice with Fragile X Syndrome , 2000, Epilepsia.

[22]  Tobias Bonhoeffer,et al.  Essential Role for TrkB Receptors in Hippocampus-Mediated Learning , 1999, Neuron.

[23]  H. Scharfman,et al.  Brain-derived neurotrophic factor transgenic mice exhibit passive avoidance deficits, increased seizure severity and in vitro hyperexcitability in the hippocampus and entorhinal cortex , 1999, Neuroscience.

[24]  L. C. Katz,et al.  Destabilization of Cortical Dendrites and Spines by BDNF , 1999, Neuron.

[25]  R. A. Murphy,et al.  Activity-dependent activation of TrkB neurotrophin receptors in the adult CNS. , 1999, Learning & memory.

[26]  I. Weiler,et al.  Synaptic synthesis of the Fragile X protein: possible involvement in synapse maturation and elimination. , 1999, American journal of medical genetics.

[27]  E. Tongiorgi,et al.  A non-radioactive in situ hybridization method that does not require RNAse-free conditions , 1998, Journal of Neuroscience Methods.

[28]  O. Steward,et al.  No evidence for disruption of normal patterns of mRNA localization in dendrites or dendritic transport of recently synthesized mRNA in FMR1 knockout mice, a model for human fragile‐X mental retardation syndrome , 1998, Neuroreport.

[29]  B. Oostra,et al.  The fragile X syndrome , 1997, Journal of Inherited Metabolic Disease.

[30]  I. Weiler,et al.  Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[31]  I. Weiler,et al.  Fragile X mental retardation protein is translated near synapses in response to neurotransmitter activation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[32]  Lawrence C. Katz,et al.  Opposing Roles for Endogenous BDNF and NT-3 in Regulating Cortical Dendritic Growth , 1997, Neuron.

[33]  W. Hwu,et al.  FMR1 enhancer is regulated by cAMP through a cAMP-responsive element. , 1997, DNA and cell biology.

[34]  E. Castrén,et al.  Brain-derived neurotrophic factor promotes the differentiation of various hippocampal nonpyramidal neurons, including Cajal-Retzius cells, in organotypic slice cultures , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[35]  H. Thoenen.  Neurotrophins and Neuronal Plasticity , 1995, Science.

[36]  Lawrence C. Katz,et al.  Neurotrophins regulate dendritic growth in developing visual cortex , 1995, Neuron.

[37]  T Bonhoeffer,et al.  Hippocampal long-term potentiation is impaired in mice lacking brain-derived neurotrophic factor. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[38]  J. Mandel,et al.  A heterogeneous set of FMR1 proteins is widely distributed in mouse tissues and is modulated in cell culture. , 1995, Human molecular genetics.

[39]  M. Gassmann,et al.  Tissue-specific expression of a FMR1/β-galactosidase fusion gene in transgenic mice , 1995 .

[40]  E. Castrén,et al.  Brain-derived neurotrophic factor messenger RNA is expressed in the septum, hypothalamus and in adrenergic brain stem nuclei of adult rat brain and is increased by osmotic stimulation in the paraventricular nucleus , 1995, Neuroscience.

[41]  R. D'Hooge,et al.  Fmr1 knockout mice: A model to study fragile X mental retardation , 1994, Cell.

[42]  Rudolf Jaenisch,et al.  Mice lacking brain-derived neurotrophic factor develop with sensory deficits , 1994, Nature.

[43]  S. Warren,et al.  FMR1 protein: conserved RNP family domains and selective RNA binding. , 1993, Science.

[44]  M. Barbacid,et al.  Targeted disruption of the trkB neurotrophin receptor gene results in nervous system lesions and neonatal death , 1993, Cell.

[45]  J. Mallet,et al.  Nucleus basalis magnocellularis and hippocampus are the major sites of FMR-1 expression in the human fetal brain , 1993, Nature Genetics.

[46]  P. Conn.  Methods in neurosciences , 1991 .

[47]  W. Brown,et al.  Analysis of neocortex in three males with the fragile X syndrome. , 1991, American journal of medical genetics.

[48]  K. Wisniewski,et al.  The Fra(X) syndrome: neurological, electrophysiological, and neuropathological abnormalities. , 1991, American journal of medical genetics.

[49]  T. Hunter,et al.  trkB, a neural receptor protein-tyrosine kinase: evidence for a full-length and two truncated receptors , 1991, Molecular and cellular biology.

[50]  H. Phillips,et al.  Widespread expression of BDNF but not NT3 by target areas of basal forebrain cholinergic neurons. , 1990, Science.

[51]  Y. Barde,et al.  Regional distribution of brain‐derived neurotrophic factor mRNA in the adult mouse brain. , 1990, The EMBO journal.

[52]  Y. Barde,et al.  Identification and characterization of a novel member of the nerve growth factor/brain-derived neurotrophic factor family , 1990, Nature.

[53]  M. Barbacid,et al.  trkB, a novel tyrosine protein kinase receptor expressed during mouse neural development. , 1989, The EMBO journal.

[54]  H. Wiśniewski,et al.  Adult fragile X syndrome , 1985, Acta Neuropathologica.

[55]  E. Huang,et al.  Neurotrophins: roles in neuronal development and function. , 2001, Annual review of neuroscience.

[56]  L C Katz,et al.  Neurotrophins and synaptic plasticity. , 1999, Annual review of neuroscience.

[57]  E. Castrén,et al.  In Vitro and in Vivo Methods for Evaluating Actions of Cytokines on Nerve Growth Factor Production in Central Nervous System , 1993 .

[58]  Pediatrics, and , 2022 .